Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mosteller

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
BMC Medical Genomics|June 14, 2013
Saliva sampling in global clinical studies: the impact of low sampling volume on performance of DNA in downstream genotyping experimentsDavid J Pulford, Michael Mosteller, J David Briley, et al.
Pharmacogenetics and Genomics|September 6, 2014
Exploring the roles of UGT1A1 and UGT1A3 in oral clearance of GSK2190915, a 5-lipoxygenase-activating protein inhibitorMichael Mosteller, Lynn D Condreay, Elizabeth C Harris, et al.
Pharmacogenomics|February 12, 2009
Genetic association studies to detect adverse drug reactions: abacavir hypersensitivity as an exampleArlene R Hughes, Cynthia H Brothers, Michael Mosteller, et al.
The Journal of Allergy and Clinical Immunology|August 16, 2016
No evidence of large genetic effects on steroid response in asthma patientsMichael Mosteller, Louise Hosking, Kay Murphy, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 28, 2013
Genetic analysis of asthma exacerbationsWayne H Anderson, Beena T Koshy, Lingkang Huang, et al.
Tropical Medicine & International Health : TM & IH|November 25, 2010
Distribution of HLA-B alleles in a Ugandan HIV-infected adult population: NORA pharmacogenetic substudy of DARTPaula Munderi, Wendy B Snowden, Ann Sarah Walker, et al.
Pharmacogenetics and Genomics|November 16, 2007
Genetic variants in the epithelial sodium channel associate with oedema in type 2 diabetic patients receiving the peroxisome proliferator-activated receptor gamma agonist farglitazarColin Spraggs, Alun McCarthy, Linda McCarthy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patientsMichael Saag, Rukmini Balu, Elizabeth Phillips, et al.
Pharmacogenomics|March 16, 2004
Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populationsArlene R Hughes, Michael Mosteller, Aruna T Bansal, et al.
European Journal of Clinical Pharmacology|August 23, 2014
Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravirIvy Song, Julie Borland, Shuguang Chen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
BMC Medical Genomics|June 14, 2013
Saliva sampling in global clinical studies: the impact of low sampling volume on performance of DNA in downstream genotyping experimentsDavid J Pulford, Michael Mosteller, J David Briley, et al.
Pharmacogenetics and Genomics|September 6, 2014
Exploring the roles of UGT1A1 and UGT1A3 in oral clearance of GSK2190915, a 5-lipoxygenase-activating protein inhibitorMichael Mosteller, Lynn D Condreay, Elizabeth C Harris, et al.
Pharmacogenomics|February 12, 2009
Genetic association studies to detect adverse drug reactions: abacavir hypersensitivity as an exampleArlene R Hughes, Cynthia H Brothers, Michael Mosteller, et al.
The Journal of Allergy and Clinical Immunology|August 16, 2016
No evidence of large genetic effects on steroid response in asthma patientsMichael Mosteller, Louise Hosking, Kay Murphy, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 28, 2013
Genetic analysis of asthma exacerbationsWayne H Anderson, Beena T Koshy, Lingkang Huang, et al.
Tropical Medicine & International Health : TM & IH|November 25, 2010
Distribution of HLA-B alleles in a Ugandan HIV-infected adult population: NORA pharmacogenetic substudy of DARTPaula Munderi, Wendy B Snowden, Ann Sarah Walker, et al.
Pharmacogenetics and Genomics|November 16, 2007
Genetic variants in the epithelial sodium channel associate with oedema in type 2 diabetic patients receiving the peroxisome proliferator-activated receptor gamma agonist farglitazarColin Spraggs, Alun McCarthy, Linda McCarthy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patientsMichael Saag, Rukmini Balu, Elizabeth Phillips, et al.
Pharmacogenomics|March 16, 2004
Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populationsArlene R Hughes, Michael Mosteller, Aruna T Bansal, et al.
European Journal of Clinical Pharmacology|August 23, 2014
Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravirIvy Song, Julie Borland, Shuguang Chen, et al.
Pageof 2